Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd (600332) — Tangible Net Worth Ratio

Latest as of March 2026: 92.4%

Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd (600332) has a Tangible Net Worth Ratio of 92.4% as of March 2026. This metric is calculated by deducting intangible assets (CN¥3.18 Billion) from net assets (CN¥41.89 Billion) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See Guangzhou Baiyunshan Pharmaceutical Hold (600332) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.

Tangible NW Ratio

92.4%
Tangible equity / total equity

Net Assets (Equity)

CN¥41.89 Billion
CNY

Intangible Assets

CN¥3.18 Billion
Goodwill, patents, brand value

Total Assets

CN¥89.76 Billion
CNY

Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Tangible Net Worth Ratio (1997–2025)

This chart shows how Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd's Tangible Net Worth Ratio has changed across 29 annual periods from 1997 to 2025. As of March 2026, the ratio stands at 92.4%, reflecting net assets of CN¥41.89 Billion with intangible assets of CN¥3.18 Billion CNY. See 600332 defensive interval ratio to measure how many days the company can operate on defensive assets alone.

Annual Tangible Net Worth Ratio for Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd (1997–2025)

The table below presents the year-by-year Tangible Net Worth Ratio for Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd from 1997 to 2025, covering 29 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For the full company profile including market capitalisation, see market cap of Guangzhou Baiyunshan Pharmaceutical Hold.

Year Tangible NW Ratio Net Assets (CNY) Intangible Assets Total Assets Change (pp)
2025 92.3% CN¥41.12 Billion CN¥3.19 Billion CN¥84.51 Billion ▲ +0.7 pp
2024 91.5% CN¥37.77 Billion CN¥3.20 Billion CN¥81.68 Billion ▲ +0.2 pp
2023 91.3% CN¥36.68 Billion CN¥3.20 Billion CN¥78.59 Billion ▼ -0.3 pp
2022 91.6% CN¥33.64 Billion CN¥2.83 Billion CN¥74.67 Billion ▼ -0.1 pp
2021 91.7% CN¥31.33 Billion CN¥2.59 Billion CN¥66.12 Billion ▲ +0.4 pp
2020 91.3% CN¥28.21 Billion CN¥2.45 Billion CN¥59.76 Billion ▲ +0.9 pp
2019 90.4% CN¥25.99 Billion CN¥2.49 Billion CN¥56.89 Billion ▼ -5.2 pp
2018 95.6% CN¥23.14 Billion CN¥1.01 Billion CN¥51.48 Billion ▼ -0.6 pp
2017 96.2% CN¥19.26 Billion CN¥728.81 Million CN¥28.31 Billion ▲ +0.0 pp
2016 96.2% CN¥17.65 Billion CN¥671.32 Million CN¥25.90 Billion ▲ +2.5 pp
2015 93.7% CN¥8.68 Billion CN¥545.68 Million CN¥15.87 Billion ▼ -1.3 pp
2014 95.0% CN¥7.96 Billion CN¥399.45 Million CN¥14.21 Billion ▲ +0.3 pp
2013 94.7% CN¥7.02 Billion CN¥372.57 Million CN¥12.25 Billion ▼ -3.1 pp
2012 97.8% CN¥4.22 Billion CN¥93.24 Million CN¥6.24 Billion ▲ +0.3 pp
2011 97.5% CN¥3.90 Billion CN¥95.93 Million CN¥4.85 Billion ▲ +0.2 pp
2010 97.3% CN¥3.64 Billion CN¥97.96 Million CN¥4.48 Billion ▲ +0.3 pp
2009 97.0% CN¥3.40 Billion CN¥100.38 Million CN¥4.22 Billion ▲ +0.3 pp
2008 96.8% CN¥3.22 Billion CN¥104.04 Million CN¥4.13 Billion ▲ +0.9 pp
2007 95.9% CN¥3.29 Billion CN¥135.70 Million CN¥6.21 Billion ▼ -0.3 pp
2006 96.2% CN¥2.95 Billion CN¥111.40 Million CN¥5.41 Billion ▼ -0.3 pp
2005 96.5% CN¥2.81 Billion CN¥98.68 Million CN¥5.10 Billion ▲ +0.4 pp
2004 96.1% CN¥2.64 Billion CN¥103.35 Million CN¥5.18 Billion ▼ -0.3 pp
2003 96.4% CN¥2.60 Billion CN¥93.72 Million CN¥4.71 Billion ▲ +0.3 pp
2002 96.1% CN¥2.42 Billion CN¥93.77 Million CN¥4.17 Billion ▲ +0.6 pp
2001 95.5% CN¥2.28 Billion CN¥102.14 Million CN¥3.70 Billion ▲ +3.0 pp
2000 92.6% CN¥1.50 Billion CN¥111.47 Million CN¥3.06 Billion ▲ +0.1 pp
1999 92.4% CN¥1.50 Billion CN¥113.84 Million CN¥3.03 Billion ▲ +0.4 pp
1998 92.0% CN¥1.40 Billion CN¥111.50 Million CN¥3.00 Billion ▲ +0.5 pp
1997 91.5% CN¥1.30 Billion CN¥110.23 Million CN¥3.00 Billion
pp = percentage points